{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:15:37Z","timestamp":1770077737201,"version":"3.49.0"},"reference-count":58,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2012,7,26]],"date-time":"2012-07-26T00:00:00Z","timestamp":1343260800000},"content-version":"vor","delay-in-days":7481,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[1992,2]]},"abstract":"<jats:p>1. Captopril was evaluated as an adjuvant to diuretic and digoxin therapy in heart failure in old age, using walking ability, minute ventilation and oxygen consumption and plasma atrial natriuretic factor (ANF) concentration as measures of outcome. 2. Twenty patients, mean (s.d.) age 81 (6) years, entered a double\u2010blind, randomised, crossover study of three treatments, a twice daily regimen of captopril (AA), at a dosage established by titration against serum angiotensin converting enzyme (ACE) activity, the same dosage in the morning with placebo at night (AP), and twice daily placebo (PP). Each treatment lasted 3 weeks. A 2 week run\u2010in period on triple therapy, with AA captopril, was used to assess stability and compliance. Seventeen completed all treatments: three completed two. 3. Any benefit of captopril was modest and there was deterioration in gait on the titrated dosage 3 months afterwards (P = 0.04). Efficacy in the old may be greatest when the titrated dose (25 or 50 mg) is given once daily: the multiple daily doses recommended may be unnecessarily demanding. 4. Walking performance was measured by gait analysis (GA) at free walking speed and by a simple walking test (SWT), in which patients stopped at the first relevant symptom. There was a consistent tendency for four measures of performance (GA: speed, stride length and double support time; SWT distance) to be best on the AP treatment, next best on AA, and worst on PP but for the fifth, SWT speed, AP and AA were similar. The trend appeared most marked for SWT distance, mean (s.e. mean) values for AP, AA and PP being 123 (15), 94 (16) and 75 (16) m, respectively. However, the treatment effect did not reach statistical significance at the 0.05 level. 5. There was no significant difference between treatments in minute ventilation, minute oxygen consumption, or their ratio, either at rest or on exercise. 6. Resting ANF concentrations were nearly four times higher (P = 0.0001) in the patients than those, mean (s.e. mean) 66 (5) pmol l\u20101, in eleven healthy volunteers of mean age 80 (6) years, and the increase on exercise, seen in the controls (P less than 0.01), was absent. In the patients the resting plasma ANF concentration was significantly affected by treatment (P = 0.03), being less on both AP, 245 (9), and AA, 214 (9) than on PP, 264 (10) pmol l\u20101 (P = 0.02 and 0.03, respectively). 7. Baseline serum ACE activity was induced on active treatment. The change in ACE activity at 3 h post an active dose was significantly greater on AP than AA (P = 0.005). The increased sensitivity to inhibition during once daily administration was reflected in mean arterial pressure. The pre\u2010dose standing pressure was less on AP than on PP (P less than 0.05), and the change in postural fall (pre\u2010dose minus 2 h post), was greater (P = 0.004), but AA and PP were similar in these respects.(ABSTRACT TRUNCATED AT 400 WORDS)<\/jats:p>","DOI":"10.1111\/j.1365-2125.1992.tb04020.x","type":"journal-article","created":{"date-parts":[[2012,7,27]],"date-time":"2012-07-27T03:13:06Z","timestamp":1343358786000},"page":"167-178","source":"Crossref","is-referenced-by-count":4,"title":["Effect of captopril on functional, physiological and biochemical outcome criteria in aged heart failure patients."],"prefix":"10.1111","volume":"33","author":[{"given":"CJ","family":"O'Neill","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Charlett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RJ","family":"Dobbs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AA","family":"Deshmukh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SG","family":"Bowes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Weller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PW","family":"Nicholson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JS","family":"Milledge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SM","family":"Dobbs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,7,26]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1100007"},{"issue":"2","key":"e_1_2_1_3_1","first-page":"137","article-title":"The plasma atrial natriuretic peptide response to treatment of acute cardiac failure, spontaneous supraventricular tachycardia and induced re\u2010entrant tachycardia in man","volume":"4","author":"Anderson J. V.","year":"1986","journal-title":"J. Hypertension"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.73.6.1155"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.92"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.3109\/00365518709168929"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1990.tb03738.x"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1981.tb01151.x"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.2935937"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(83)80316-7"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00561372"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.52.5.530"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.291.6505.1309"},{"key":"e_1_2_1_14_1","first-page":"1012","article-title":"Enalapril and hypertension","volume":"41","author":"Cohen L. M.","year":"1984","journal-title":"Am. J. Psychiat."},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198706043162301"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198606263142602"},{"key":"e_1_2_1_17_1","first-page":"52","volume-title":"Source book of geriatric assessment","author":"Denham M. J.","year":"1984"},{"issue":"6","key":"e_1_2_1_18_1","first-page":"512","article-title":"Relationship between haemodynamic parameters and concentrations of atrial natriuretic peptide in human plasma","volume":"4","author":"Dietz R.","year":"1986","journal-title":"J. Hypertension"},{"key":"e_1_2_1_19_1","first-page":"139","volume-title":"Patient compliance in medical practice and clinical trials","author":"Dobbs R. J.","year":"1991"},{"key":"e_1_2_1_20_1","first-page":"606P","article-title":"Could free\u2010walking speed reflect striatal dopamaine","volume":"31","author":"Dobbs R. J.","year":"1991","journal-title":"Br. J. clin. Pharmac."},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199120030-00001"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02455997"},{"key":"e_1_2_1_23_1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/dtb.23.23.89","article-title":"ACE inhibitors: enalapril and captopril compared","volume":"23","author":"Drug and Therapeutics Bulletin","year":"1985","journal-title":"Drugs and Therapeutics Bulletin"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(12)61998-3"},{"key":"e_1_2_1_25_1","first-page":"238","article-title":"Hemodynamic vertebrobasilar insufficiency as an adverse effect of anti\u2010hypertensive therapy","volume":"23","author":"Fagan S. C.","year":"1989","journal-title":"Drug Intell. clin. Pharm."},{"issue":"141","key":"e_1_2_1_26_1","first-page":"528","article-title":"Adverse effects of angiotensin\u2010converting enzyme inhibitors","author":"Ferner R. E.","year":"1990","journal-title":"Adverse drug reaction bulletin"},{"key":"e_1_2_1_27_1","volume-title":"The design analysis of clinical experiments","author":"Fleiss J. L.","year":"1986"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(79)90794-0"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(85)80090-5"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/8.suppl_B.117"},{"key":"e_1_2_1_31_1","volume-title":"Generalised linear interactive modelling","author":"GLIM","year":"1986"},{"key":"e_1_2_1_32_1","first-page":"12P","article-title":"The oxylog","volume":"267","author":"Humphrey S. J. E.","year":"1977","journal-title":"J. Physiol."},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.293.6554.1073-a"},{"issue":"1","key":"e_1_2_1_34_1","first-page":"71","article-title":"Relationship of antihypertensive effect of enalapril to Serum MK\u2010422 levels and angiotensin converting enzyme inhibition","volume":"1","author":"Johnson C. I.","year":"1983","journal-title":"J. Hypertension"},{"key":"e_1_2_1_35_1","volume-title":"Monographs on statistics and applied probability. 34. Design and analysis of crossover trials","author":"Jones B.","year":"1988"},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)90955-4"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.67.4.807"},{"issue":"2","key":"e_1_2_1_38_1","first-page":"119","article-title":"Plasma atrial natriuretic peptide values in cardiac disease","volume":"4","author":"Lang R. E.","year":"1986","journal-title":"J. Hypertension"},{"key":"e_1_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.58.6.559"},{"key":"e_1_2_1_40_1","doi-asserted-by":"publisher","DOI":"10.1177\/000456328502200218"},{"key":"e_1_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4899-3244-0"},{"key":"e_1_2_1_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00607965"},{"key":"e_1_2_1_43_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197112232852601"},{"key":"e_1_2_1_44_1","doi-asserted-by":"publisher","DOI":"10.3109\/10641968709161445"},{"key":"e_1_2_1_45_1","doi-asserted-by":"publisher","DOI":"10.1042\/cs0680483"},{"key":"e_1_2_1_46_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.293.6541.239"},{"key":"e_1_2_1_47_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-64-1-81"},{"key":"e_1_2_1_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00609243"},{"key":"e_1_2_1_49_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198608283150901"},{"key":"e_1_2_1_50_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.293.6544.409"},{"key":"e_1_2_1_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1984.tb02338.x"},{"key":"e_1_2_1_52_1","doi-asserted-by":"publisher","DOI":"10.2307\/2347973"},{"key":"e_1_2_1_53_1","first-page":"59","article-title":"Atrial natriuretic polypeptide during exercise in healthy men","volume":"116","author":"Saito Y.","year":"1987","journal-title":"Acta Endocrinol."},{"key":"e_1_2_1_54_1","first-page":"967","volume-title":"User's guide","author":"SAS\/STAT","year":"1988"},{"key":"e_1_2_1_55_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198609183151217"},{"key":"e_1_2_1_56_1","doi-asserted-by":"publisher","DOI":"10.2307\/2346653"},{"key":"e_1_2_1_57_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1012460"},{"key":"e_1_2_1_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)90178-3"},{"key":"e_1_2_1_59_1","first-page":"575","volume-title":"Biotelemetry X. Proceedings of Tenth International Symposium on biotelemetry","author":"Weller C.","year":"1989"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2125.1992.tb04020.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2125.1992.tb04020.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T15:49:52Z","timestamp":1698076192000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2125.1992.tb04020.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,2]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1992,2]]}},"alternative-id":["10.1111\/j.1365-2125.1992.tb04020.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2125.1992.tb04020.x","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,2]]}}}